Dynamic change of metabolic dysfunction-associated steatotic liver disease in patients with hepatitis C virus infection after achieving sustained virologic response with direct-acting antivirals
ConclusionsThe prevalence of MASLD decreased after achieving SVR12 with DAAs. Patients with pre-existing T2D showed a diminished probability of MASLD regression and a heightened risk of MASLD emergence post-SVR12.
Source: Journal of Gastroenterology - Category: Gastroenterology Source Type: research
More News: Cardiology | Diabetes | Diabetes Type 2 | Endocrinology | Gastroenterology | Heart | Hepatitis | Hepatitis C | Liver | Liver Disease | Study | Urology & Nephrology | Virology